$AIMT & KKR Enter into $170M Loan Agreement to Fund AR101 Commercialization and Pipeline Advancement httpswww.businesswire.comnewshome20190104005280enAimmuneTherapeuticsKKREnter170MLoanAgreement.XC9pruaYfRg.twitterÂ
$AIMT & KKR Enter into $170M Loan Agreement to Fund AR101 Commercialization and Pipeline Advancement https://www.businesswire.com/news/home/20190104005280/en/Aimmune-Therapeutics-KKR-Enter-170M-Loan-Agreement#.XC9pruaYfRg.twitter …
More From BioPortfolio on "$AIMT & KKR Enter into $170M Loan Agreement to Fund AR101 Commercialization and Pipeline Advancement https://www.businesswire.com/news/home/20190104005280/en/Aimmune-Therapeutics-KKR-Enter-170M-Loan-Agreement#.XC9pruaYfRg.twitter …"